Ming Hou, Ph.D. - Publications

Affiliations: 
2003 University of Toronto, Toronto, ON, Canada 
Area:
Industrial Engineering

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Wang X, Li L, Wang Y, Li X, Feng Q, Hou Y, Ma C, Gao C, Hou M, Peng J. High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia. Frontiers in Immunology. 10: 451. PMID 30936868 DOI: 10.3389/fimmu.2019.00451  0.32
2019 Zhao Y, Han P, Liu L, Wang X, Xu P, Wang H, Yu T, Sun Y, Li L, Sun T, Liu X, Zhou H, Qiu J, Wang L, Peng J, ... ... Hou M, et al. Indirubin modulates CD4 T-cell homeostasis via PD1/PTEN/AKT signalling pathway in immune thrombocytopenia. Journal of Cellular and Molecular Medicine. PMID 30609280 DOI: 10.1111/jcmm.14089  0.32
2018 Luo L, Wu Y, Niu T, Han Y, Feng Y, Ding Q, Huang R, Zhang X, Feng J, Hou M, Peng J, Li Y, Zhou Y, Su L, Yang L, et al. A multicenter, prospective evaluation of the Chinese Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation. Thrombosis Research. 173: 131-140. PMID 30529391 DOI: 10.1016/j.thromres.2018.11.022  0.32
2018 Mei H, Jiang Y, Luo L, Huang R, Su L, Hou M, Wang X, Deng J, Hu Y. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study. Thrombosis Research. 173: 20-26. PMID 30458338 DOI: 10.1016/j.thromres.2018.11.010  0.32
2018 Liu XG, Bai XC, Chen FP, Cheng YF, Dai KS, Fang MY, Feng JM, Gong YP, Guo T, Guo XH, Han Y, Hong LJ, Hu Y, Hua BL, Huang RB, ... ... Hou M, et al. Chinese guidelines for treatment of adult primary immune thrombocytopenia. International Journal of Hematology. PMID 29619624 DOI: 10.1007/s12185-018-2445-z  0.32
2017 Wu Y, Luo L, Niu T, Han Y, Feng Y, Ding Q, Huang R, Zhang X, Feng J, Hou M, Peng J, Li Y, Zhou Y, Su L, Yang L, et al. Evaluation of the new Chinese Disseminated Intravascular Coagulation Scoring System in critically ill patients: A multicenter prospective study. Scientific Reports. 7: 9057. PMID 28831134 DOI: 10.1038/s41598-017-09190-5  0.32
2017 Shi Y, Jia B, Xu W, Li W, Liu T, Liu P, Zhao W, Zhang H, Sun X, Yang H, Zhang X, Jin J, Jin Z, Li Z, Qiu L, ... ... Hou M, et al. Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China. Journal of Hematology & Oncology. 10: 69. PMID 28298231 DOI: 10.1186/s13045-017-0439-6  0.32
2015 Hu Y, Wang X, Yu S, Hou Y, Ma D, Hou M. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia. Expert Opinion On Therapeutic Targets. 19: 723-32. PMID 25976230 DOI: 10.1517/14728222.2015.1016499  0.32
2015 Lai YY, Huang XJ, Li J, Zou P, Xu ZF, Sun H, Shao ZH, Zhou DB, Chen FP, Liu ZG, Zhu HL, Wu DP, Wang C, Zhang Y, Li Y, ... Hou M, et al. Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China. Leukemia Research. 39: 530-5. PMID 25823643 DOI: 10.1016/j.leukres.2015.02.005  0.32
2015 Zhou H, Xu M, Qin P, Zhang HY, Yuan CL, Zhao HG, Cui ZG, Meng YS, Wang L, Zhou F, Wang X, Li DQ, Bi KH, Zhu CS, Guo CS, ... ... Hou M, et al. A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP. Blood. 125: 1541-7. PMID 25575541 DOI: 10.1182/blood-2014-06-581868  0.32
2014 Feng L, Li P, Lu C, Tang W, Mahapatra T, Wang Y, Wang X, Ma Y, Ben Y, Cao X, Mahapatra S, Ling M, Gou A, Wang Y, Xiao J, ... Hou M, et al. Burden and correlates of geriatric depression in the Uyghur elderly population, observation from Xinjiang, China. Plos One. 9: e114139. PMID 25437860 DOI: 10.1371/journal.pone.0114139  0.32
2014 Feng L, Li P, Wang X, Hu Z, Ma Y, Tang W, Ben Y, Mahapatra T, Cao X, Mahapatra S, Ling M, Gou A, Wang Y, Xiao J, Hou M, et al. Distribution and determinants of non communicable diseases among elderly Uyghur ethnic group in Xinjiang, China. Plos One. 9: e105536. PMID 25141133 DOI: 10.1371/journal.pone.0105536  0.32
2014 Chen F, Wang J, Hou M, Zhao H, Yang E, Ran X, Wang M, Yu W, Xu R, Wang Z, Bi K, Wang X, Liu G, Yang S, Fan J, et al. [Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 35: 388-92. PMID 24857206 DOI: 10.3760/cma.j.issn.0253-2727.2014.05.003  0.32
2014 Shan NN, Hu Y, Hou M, Gao J, Wang X, Liu X, Li Y. Decreased Tim-3 and its correlation with Th1 cells in patients with immune thrombocytopenia. Thrombosis Research. 133: 52-6. PMID 24231118 DOI: 10.1016/j.thromres.2013.10.029  0.32
2013 Du HZ, Wang Q, Ji J, Shen BM, Wei SC, Liu LJ, Ding J, Ma DX, Wang W, Peng J, Hou M. Expression of IL-27, Th1 and Th17 in patients with aplastic anemia. Journal of Clinical Immunology. 33: 436-45. PMID 23054344 DOI: 10.1007/s10875-012-9810-0  0.32
2011 Chen C, Wang W, Xu CG, Hou M, Wang LQ, Liu CF, Song Q, Ji CY. [Monitoring of plasma concentration of imatinib mesylate in patients with chronic myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 32: 450-3. PMID 22213863  0.32
2011 Shan NN, Ji XB, Wang X, Li Y, Liu X, Zhu XJ, Hou M. In vitro recovery of Th1/Th2 balance in PBMCs from patients with immune thrombocytopenia through the actions of IL-18BPa/Fc. Thrombosis Research. 128: e119-24. PMID 21911248 DOI: 10.1016/j.thromres.2011.07.012  0.32
2011 Shan NN, Wang X, Jiang YJ, Sui XH, Li Y, Liu X, Hou M. [Secretion of IL-18 and IL-18 binding protein from splenocytes of ITP patients in vitro]. Zhongguo Shi Yan Xue Ye Xue Za Zhi / Zhongguo Bing Li Sheng Li Xue Hui = Journal of Experimental Hematology / Chinese Association of Pathophysiology. 19: 975-8. PMID 21867627  0.32
2011 Yang Q, Xu S, Li X, Wang B, Wang X, Ma D, Yang L, Peng J, Hou M. Pathway of Toll-like receptor 7/B cell activating factor/B cell activating factor receptor plays a role in immune thrombocytopenia in vivo. Plos One. 6: e22708. PMID 21818370 DOI: 10.1371/journal.pone.0022708  0.32
2011 Zhu YC, Wang W, Zhou YH, Wang XM, Wang X, Wang YL, Sun GZ, Hou M. [Clinical study of standard dose of rituximab for the treatment of refractory primary immune thrombocytopenia]. Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi. 32: 163-7. PMID 21535953  0.32
2011 Yang Q, Wang B, Yu H, Zhu Y, Wang X, Jiang H, Wang C, Peng J, Hou M. TLR7 promotes Th1 polarization in immune thrombocytopenia. Thrombosis Research. 128: 237-42. PMID 21458848 DOI: 10.1016/j.thromres.2011.02.024  0.32
2011 Shan NN, Wang X, Zhu XJ, Peng J, Hou M. [Role of IL-18/IL-18BP balance in spleen of patients with primary immune thrombocytopenia]. Zhonghua Yi Xue Za Zhi. 91: 239-42. PMID 21418867  0.32
Show low-probability matches.